Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Connecticut

Chase Medical Research, LLC
Waterbury Connecticut 06708

A Randomized, Double-Blind, Placebo-Controlled Parallel Arm Study to Evaluate the Safety, Tolerability, and Effect on Atrial Fibrillation Burden of BMS-919373 in Patients with Paroxysmal Atrial Fibrillation

District of Columbia

Florida

Holy Cross Jim Moran Heart and Vascular Research Institute
Coral Springs Florida 33065

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II - ORBIT AF II - Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is designed to evaluate the utilization of target-specific antithrombotic agents, such as factor Xa (FXa) inhibitors and direct thrombin inhibitors, and associated outcomes.

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa Florida 33606

A Phase IV Trial To Assess The Effectiveness Of Apixaban Compared With Usual Care Anticoagulation In Subjects With Non-valvular Atrial Fibrillation Undergoing Cardioversion

Georgia

Indiana

Kentucky

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

“A Clinical Evaluation of the Safety of the St. Jude Medical Quartet 1457Q Left Ventricular Lead, an Investigational Device Exemption (IDE) Study" Quartet 1457Q IDE

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub- Clinical Atrial fibrillation (ARTESiA)

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40353

Assessment of the WATCHMANTM Device in Patients Unsuitable for Oral Anticoagulation ASAP-TOO

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

BHLEX analysis for all modality atrial fibrillation ablation for safety and efficacy – AFIB Registry

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

CRT IMPLANT STRATEGY USING THE LONGEST ELECTRICAL DELAY FOR NON-LEFT BUNDLE BRANCH BLOCK PATIENTS (ENHANCE CRT)

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation reMARQable

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

QP ExCELs – Sentus QP: Extended CRT Evaluation with Quadripolar Left Ventricular Leads

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40503

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy (SMART CRT)

Louisiana

Massachusetts

Michigan

Mississippi

North Carolina

North Dakota

St. Alexius Medical Center
Bismarck North Dakota 58501

A research study for patients who are being treated for atrial fibrillation

Ohio

Texas

Baylor Scott & White Research Institute
Dallas Texas 75204

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Baylor Scott & White Research Institute
Dallas Texas 75204

Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)

Virginia